Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Costa

Showing results (11-20 of 224) with videos related to

Pageof 23
Sort By:
Expert Review of Anticancer Therapy|February 10, 2012
Benign and malignant apocrine lesions of the breastRenê Gerhard, José Luis Costa, Fernando Schmitt
Supportive Cancer Therapy|July 18, 2008
Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastasesLuis Costa, Allan Lipton, Robert E Coleman
Cells|August 27, 2021
The Roadmap of RANKL/RANK Pathway in CancerSandra Casimiro, Guilherme Vilhais, Inês Gomes, et al.
FEMS Microbiology Ecology|August 29, 2009
Sequence based data supports a single Nostoc strain in individual coralloid roots of cycadsJosé-Luis Costa, Esperanza Martínez Romero, Peter Lindblad
Anticancer Research|April 30, 2016
Low Molecular Weight Protein Tyrosine Phosphatase Slow Isoform Knockdown in MDA-MB-435 Cells Decreases RAW 264.7 Osteoclastic DifferentiationIrina Alho, Luis Costa, Manuel Bicho, et al.
Cancers|October 14, 2023
The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast CancerInês Gomes, Catarina Abreu, Luis Costa, et al.
Plos One|October 3, 2013
Low molecular weight protein tyrosine phosphatase isoforms regulate breast cancer cells migration through a RhoA dependent mechanismIrina Alho, Luis Costa, Manuel Bicho, et al.
Cancer Treatment Reviews|April 10, 2012
Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerationsPeyman Hadji, Matti Aapro, Luis Costa, et al.
Environmental Toxicology and Chemistry|October 11, 2013
Persistence and sorption of imazapyr in three Argentinean soilsValeria Rosana Gianelli, Francisco Bedmar, José Luis Costa
Critical Reviews in Oncology/Hematology|March 1, 2011
Anticancer evidence for zoledronic acid across the cancer continuumLuis Costa, Peter Harper, Robert E Coleman, et al.
Pageof 23

Showing results (11-20 of 224) with videos related to

Sort By:
Pageof 23
Expert Review of Anticancer Therapy|February 10, 2012
Benign and malignant apocrine lesions of the breastRenê Gerhard, José Luis Costa, Fernando Schmitt
Supportive Cancer Therapy|July 18, 2008
Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastasesLuis Costa, Allan Lipton, Robert E Coleman
Cells|August 27, 2021
The Roadmap of RANKL/RANK Pathway in CancerSandra Casimiro, Guilherme Vilhais, Inês Gomes, et al.
FEMS Microbiology Ecology|August 29, 2009
Sequence based data supports a single Nostoc strain in individual coralloid roots of cycadsJosé-Luis Costa, Esperanza Martínez Romero, Peter Lindblad
Anticancer Research|April 30, 2016
Low Molecular Weight Protein Tyrosine Phosphatase Slow Isoform Knockdown in MDA-MB-435 Cells Decreases RAW 264.7 Osteoclastic DifferentiationIrina Alho, Luis Costa, Manuel Bicho, et al.
Cancers|October 14, 2023
The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast CancerInês Gomes, Catarina Abreu, Luis Costa, et al.
Plos One|October 3, 2013
Low molecular weight protein tyrosine phosphatase isoforms regulate breast cancer cells migration through a RhoA dependent mechanismIrina Alho, Luis Costa, Manuel Bicho, et al.
Cancer Treatment Reviews|April 10, 2012
Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerationsPeyman Hadji, Matti Aapro, Luis Costa, et al.
Environmental Toxicology and Chemistry|October 11, 2013
Persistence and sorption of imazapyr in three Argentinean soilsValeria Rosana Gianelli, Francisco Bedmar, José Luis Costa
Critical Reviews in Oncology/Hematology|March 1, 2011
Anticancer evidence for zoledronic acid across the cancer continuumLuis Costa, Peter Harper, Robert E Coleman, et al.
Pageof 23